We are live on ! Find out more
VCIM

Velan Capital Investment Management Portfolio holdings

AUM $160M
1-Year Est. Return 517.12%
This Fund
S&P 500
This Quarter Est. Return
+4.53%
1 Year Est. Return
+517.12%
3 Year Est. Return
+2,524.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$101M
AUM Growth
+$2.24M
Cap. Flow
+$4.08M
Cap. Flow %
4.04%
Top 10 Hldgs %
84.92%
Holding
31
New
7
Increased
6
Reduced
4
Closed
7

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$4.6M
2
HCSG icon
Healthcare Services Group
HCSG
+$3.35M
3
QIPT
Quipt Home Medical
QIPT
+$2.49M
4
TELA icon
TELA Bio
TELA
+$2.06M
5
ZYME icon
Zymeworks
ZYME
+$1.42M

Top Sells

Rank Stock Value
1
RDUS
Radius Health, Inc.
RDUS
+$18.4M
2
LNTH icon
Lantheus
LNTH
+$5.2M
3
ADMA icon
ADMA Biologics
ADMA
+$1.93M
4
CRBU icon
Caribou Biosciences
CRBU
+$1.14M
5
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
+$441K

Sector Composition

Rank Sector Weight
1 Healthcare 83.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
26
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.5B
– –
-50,000
Closed -$3.71M
NKGNW
27
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
– –
-20,000
Closed -$5K
SNCE
28
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
– –
-10,976
Closed -$441K
SLGCW
29
DELISTED
SomaLogic, Inc. Warrant
SLGCW
– –
-2,060
Closed -$2K
RDUS
30
CALL
DELISTED
Radius Health, Inc.
RDUS
– –
-50,000
Closed -$519K
RDUS
31
DELISTED
Radius Health, Inc.
RDUS
– –
-1,771,500
Closed -$18.4M
1
2

Similar funds

BFAG
Blackston Financial Advisory Group The Villages, Florida $160M AUM 16.38% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM
SMF
Sterling Manor Financial Saratoga Springs, New York $160M AUM 13.84% 1-Year Est. Return
LCA
Legend Capital Advisors New York $160M AUM
SGCM
Sanchez Gaunt Capital Management Reno, Nevada $160M AUM
RP
RIHO Partners Tucson, Arizona $159M AUM
PCC
Perry Creek Capital New York $160M AUM 3.05% 1-Year Est. Return
RCWM
Royal Capital Wealth Management Carmel, Indiana $161M AUM 18.42% 1-Year Est. Return

Velan Capital Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, Velan Capital Investment Management held 31 positions worth $101M, up 2.3% from $98.6M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Velan Capital Investment Management deployed $4.08M of net new capital in Q3 2022, opening 7 new positions and adding to 6 existing holdings. Its largest new stake was Zymeworks: 234,902 shares worth $1.45M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 75% a quarter earlier.

On the sell side, the largest reduction was Lantheus, an estimated $5.2M trimmed.

  • Velan Capital Investment Management's largest Q3 2022 buy was Zymeworks: 234,902 shares worth $1.45M.
  • Velan Capital Investment Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022, an estimated $4.6M increase.
  • Velan Capital Investment Management's biggest Q3 2022 reduction was Lantheus, cutting an estimated $5.2M.
  • Velan Capital Investment Management fully exited Radius Health, Inc. in Q3 2022, selling an estimated $18.4M.
  • Velan Capital Investment Management's ten largest holdings make up 85% of its $101M portfolio in Q3 2022.
  • Velan Capital Investment Management opened 7 new positions and closed 7 in Q3 2022.
  • Velan Capital Investment Management's portfolio value rose 2.3% quarter-over-quarter to $101M.

Based on Velan Capital Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.